## Correct Answer: C. Biliary obstruction Biliary obstruction causes jaundice through impaired bile flow, preventing the delivery of bile salts to the intestine. This critically impairs the **absorption of fat-soluble vitamins**, particularly vitamin K. Without adequate vitamin K, the liver cannot synthesize the **vitamin K-dependent clotting factors (II, VII, IX, X)**, leading to a coagulopathy manifested as bleeding. The key discriminator is that this coagulopathy is **reversible with vitamin K supplementation** because the hepatic synthetic machinery remains intact—only substrate availability is compromised. Once vitamin K is administered, the intestinal absorption improves (if obstruction is partial or resolves) or the exogenous vitamin K bypasses the absorption defect, allowing rapid synthesis of clotting factors and normalization of bleeding. This contrasts sharply with hepatocellular injury, where the liver parenchyma itself is damaged and cannot synthesize clotting factors even with vitamin K. In biliary obstruction, the liver function tests show elevated conjugated (direct) bilirubin and alkaline phosphatase, but prothrombin time (PT) corrects within 24–48 hours of vitamin K administration—a hallmark finding that clinches the diagnosis. ## Why the other options are wrong **A. Autoimmune hepatitis** — Autoimmune hepatitis is a hepatocellular injury disorder causing parenchymal damage and loss of synthetic function. Although it presents with jaundice and bleeding, the coagulopathy is **not corrected by vitamin K** because the problem is hepatocyte destruction, not vitamin K malabsorption. PT remains prolonged despite vitamin K administration, distinguishing it from biliary obstruction. NBE trap: both cause jaundice + bleeding, but only biliary obstruction shows vitamin K responsiveness. **B. Alpha antitrypsin deficiency** — Alpha-1 antitrypsin deficiency causes progressive hepatocellular damage and cirrhosis, leading to jaundice and coagulopathy from loss of synthetic function. Like autoimmune hepatitis, the bleeding does **not respond to vitamin K** because the underlying problem is parenchymal destruction. This is a hepatocellular disease, not a malabsorption disorder. The clinical clue of vitamin K responsiveness excludes this diagnosis entirely. **D. Factor XI deficiency** — Factor XI deficiency is a rare inherited coagulation disorder causing bleeding tendency independent of jaundice or liver disease. It does **not present with jaundice** as a primary feature and is not corrected by vitamin K (which only affects factors II, VII, IX, X). This option conflates a bleeding disorder with hepatobiliary disease—a classic NBE distractor for students who focus only on 'bleeding' without integrating the jaundice + vitamin K response pattern. ## High-Yield Facts - **Vitamin K-dependent factors (II, VII, IX, X)** require bile salts for intestinal absorption; biliary obstruction impairs their synthesis despite normal hepatic function. - **PT corrects within 24–48 hours** of vitamin K administration in biliary obstruction; persistent prolongation suggests hepatocellular disease. - **Conjugated hyperbilirubinemia + elevated ALP** with vitamin K-responsive coagulopathy is the diagnostic triad for biliary obstruction. - **Hepatocellular injury** (autoimmune hepatitis, cirrhosis, alpha-1 AT deficiency) causes vitamin K-**resistant** coagulopathy because synthetic capacity is lost. - **Gallstones, pancreatic cancer, and strictures** are common causes of biliary obstruction in India; always check for vitamin K responsiveness to differentiate from hepatitis. ## Mnemonics **VKDFC (Vitamin K-Dependent Factor Correction)** **V**itamin K corrects bleeding in **B**iliary obstruction (malabsorption), but **N**ot in **H**epatocellular disease (loss of function). Biliary = Reversible; Hepatic = Resistant. **Obstruction vs. Hepatitis: PT Test** **Obstruction** → PT corrects with vitamin K (substrate problem). **Hepatitis** → PT stays prolonged (synthetic problem). This single test differentiates the two most common causes of jaundice + bleeding. ## NBE Trap NBE pairs jaundice + bleeding to tempt students toward hepatocellular diseases (autoimmune hepatitis, cirrhosis), but the **vitamin K responsiveness** is the discriminating clue that shifts the diagnosis to biliary obstruction—a malabsorption problem, not a synthetic failure. ## Clinical Pearl In Indian clinical practice, biliary obstruction from gallstones or pancreatic head tumours is far more common than autoimmune hepatitis. The **vitamin K injection response** is the bedside pearl: if bleeding stops and PT normalizes within 2 days, you're dealing with obstruction (treat the cause); if PT remains prolonged, suspect cirrhosis or hepatitis (manage synthetic failure). _Reference: Robbins Ch. 18 (Liver & Biliary System); Harrison Ch. 297 (Jaundice & Cholestasis); KD Tripathi Ch. 12 (Fat-Soluble Vitamins)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.